HERON THERAPEUTICS, INC. /DE/ (HRTX) has 41 open-market insider trades by 15 insiders since 2014. The most active filer is Kimberly Manhard, VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| TANG Capital Management LLC | Dir10% Owner | — | 2 | $102.3M | 2018-09-12 |
| TANG Capital Partners L.P. | Dir10% Owner | — | 3 | $68.0M | 2018-03-29 |
| Robert Rosen | Pres | — | 7 | $22.7M | 2018-07-02 |
| Adam Morgan | Dir | — | 2 | $9.5M | 2026-01-30 |
| Kevin C. Tang | Dir | — | 2 | $8.1M | 2019-10-04 |
| Barry D. Quart | CEO | — | 5 | $7.7M | 2023-01-13 |
| David Efraim Rosen | 10% Owner | — | 1 | $7.2M | 2025-10-15 |
| Kimberly Manhard | VP | — | 9 | $2.9M | 2023-04-13 |
| Robert Hoffman | CFOVP | — | 1 | $1.1M | 2018-07-02 |
| John Poyhonen | CCOVP | — | 3 | $355K | 2023-04-13 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David Efraim Rosen | 10% Owner | Buy | $7.2M | 2025-08-08 |
| Adam Morgan | Director | Buy | $2.6M | 2025-08-08 |
| William P. Forbes | EVP & Chief Development Officer | Buy | $27K | 2023-11-17 |
| Ira Duarte | CFO & VP | Buy | $76K | 2023-11-16 |
| Craig A. Collard | CEO | Buy | $138K | 2023-11-16 |
| William P. Forbes | EVP & Chief Development Officer | Buy | $47K |
Companies that share insiders with HRTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-11-16 |
| Adam Morgan | Director | Buy | $6.8M | 2023-07-21 |
| Kimberly Manhard | EVP & Drug Development | Sell | $7K | 2022-05-03 |
| Waage Christian | Director | Sell | $3K | 2021-12-21 |
| Craig A. Johnson | Director | Sell | $2K | 2021-12-21 |
| Waage Christian | Director | Sell | $4K | 2021-09-21 |
| Craig A. Johnson | Director | Sell | $3K | 2021-09-21 |
| Craig A. Johnson | Director | Sell | $4K | 2021-06-21 |
| Waage Christian | Director | Sell | $5K | 2021-06-21 |
| Kimberly Manhard | EVP & Drug Development | Sell | $27K | 2021-05-03 |